Literature DB >> 35522983

Low Diastolic Blood Pressure and Mortality in Older Women. Results From the Women's Health Initiative Long Life Study.

Bernhard Haring1,2,3, Aileen P McGinn3, Victor Kamensky3, Matthew Allison4, Marcia L Stefanick5, Peter F Schnatz6, Lewis H Kuller7, Jeffrey S Berger8, Karen C Johnson9, Nazmus Saquib10, Lorena Garcia11, Phyllis A Richey9, JoAnn E Manson12, Michael Alderman3, Sylvia Wassertheil-Smoller3.   

Abstract

BACKGROUND: Recommended systolic blood pressure targets often do not consider the relationship of low diastolic blood pressure (DBP) levels with cardiovascular disease (CVD) and all-cause mortality risk, which is especially relevant for older people with concurrent comorbidities. We examined the relationship of DBP levels to CVD and all-cause mortality in older women in the Women's Health Initiative Long Life Study (WHI-LLS).
METHODS: The study sample included 7,875 women (mean age: 79 years) who underwent a blood pressure measurement at an in-person home visit conducted in 2012-2013. CVD and all-cause mortality were centrally adjudicated. Hazard ratios (HRs) were obtained from adjusted Cox proportional hazards models.
RESULTS: After 5 years follow-up, all-cause mortality occurred in 18.4% of women. Compared with a DBP of 80 mm Hg, the fully adjusted HR for mortality was 1.33 (95% confidence interval [CI]: 1.04-1.71) for a DBP of 50 mm Hg and 1.67 (95% CI: 1.29-2.16) for a DBP of 100 mm Hg. The HRs for CVD were 1.14 (95% CI: 0.78-1.67) for a DBP of 50 mm Hg and HR 1.50 (95% CI: 1.03-2.17) for a DBP of 100 mm Hg. The nadir DBP associated with lowest mortality risk was 72 mm Hg overall.
CONCLUSIONS: In older women, consideration should be given to the potential adverse effects of low and high DBP. Low DBP may serve as a risk marker. DBP target levels between 68 and 75 mm Hg may avoid higher mortality risk.
© The Author(s) 2022. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cardiovascular disease; diastolic blood pressure; hypertension; mortality; older women

Mesh:

Year:  2022        PMID: 35522983      PMCID: PMC9434234          DOI: 10.1093/ajh/hpac056

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   3.080


  31 in total

1.  Implementation of the Women's Health Initiative study design.

Authors:  Garnet L Anderson; Joann Manson; Robert Wallace; Bernedine Lund; Dallas Hall; Scott Davis; Sally Shumaker; Ching-Yun Wang; Evan Stein; Ross L Prentice
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  A likely explanation for the J-curve of blood pressure cardiovascular risk.

Authors:  William B Kannel; Peter W F Wilson; Byung-Ho Nam; Ralph B D'Agostino; J Li
Journal:  Am J Cardiol       Date:  2004-08-01       Impact factor: 2.778

3.  The "hidden side of the moon" in hypertension: When and why is dangerous low diastolic blood pressure?

Authors:  Massimo Volpe; Allegra Battistoni; Giovanna Gallo; Daniela Carnevale
Journal:  Int J Cardiol       Date:  2018-10-17       Impact factor: 4.164

4.  Lowering blood-pressure.

Authors:  I M Stewart
Journal:  Lancet       Date:  1979-08-25       Impact factor: 79.321

5.  Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study.

Authors:  Stanley S Franklin; Sohum S Gokhale; Vincent H Chow; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell; Nathan D Wong
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

6.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

7.  On-treatment diastolic blood pressure and prognosis in systolic hypertension.

Authors:  Robert H Fagard; Jan A Staessen; Lutgarde Thijs; Hilde Celis; Christopher J Bulpitt; Peter W de Leeuw; Gastone Leonetti; Jaakko Tuomilehto; Yair Yodfat
Journal:  Arch Intern Med       Date:  2007-09-24

Review 8.  The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?

Authors:  Franz H Messerli; Gurusher S Panjrath
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

9.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Eva M Lonn; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Lisheng Liu; Prem Pais; Rafael Diaz; Denis Xavier; Karen Sliwa; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Katalin Keltai; Matyas Keltai; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Alexander Parkhomenko; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Lawrence A Leiter; Dora I Molina; Robert McKelvie; Janice Pogue; Joanne Wilkinson; Hyejung Jung; Gilles Dagenais; Salim Yusuf
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

10.  Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.

Authors:  Jingen Li; Virend K Somers; Xiang Gao; Zhuo Chen; Jianqing Ju; Qian Lin; Essa A Mohamed; Shahid Karim; Hao Xu; Lijing Zhang
Journal:  JAMA Netw Open       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.